N=43

GVHD

Patients, n (%)

43 (100%)

22/43 (51%)

Positive N-PCR* - CMV in leukocytes (%)
Median time – days (range)

31/43 (72%)
65 (0-160)

15/22 (68%)

Positive N-PCRHHV-6 in serum (%)
Median time – days (range)

2/43 (4.6%)
43 (0-154)

1/22 (4.5%)

Positive N-PCRHHV-7 in serum (%)
Median time – days (range)

6/43 (13.9%)
47 (0-140)

3/22 (13.6%)

Co-infection CMV+HHV-6

2/43 (4.6%)

-

Co-infection CMV+HHV-7

4/43 (9.3%)

-

*N-PCR – nested-PCR
Table 2: Prevalence of active CMV, HHV-6 and HHV-7 infections and co-infections and occurrence of GVHD.
Goto home»